Sterling Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$9.12K Buy
2025
Q2
$6.27K Buy
2025
Q1
$3.29K Buy
2024
Q4
$4.6K Buy
2024
Q3
$4.09K Buy